

Can't find Tobramycin? Learn about real alternatives like Gentamicin, Amikacin, Moxifloxacin, and Aztreonam that your doctor may prescribe instead.
If your pharmacy is out of Tobramycin — or if cost is making it hard to get — you may be wondering what else is available. The good news is that there are several proven alternatives your doctor can consider, depending on what condition you're being treated for.
This guide covers real alternatives to Tobramycin for eye infections, systemic infections, and cystic fibrosis lung infections. Important: Never switch medications on your own. Always talk to your prescriber before making any changes.
Tobramycin is an aminoglycoside antibiotic that kills bacteria by disrupting their ability to produce proteins. It's derived from the bacterium Streptomyces tenebrarius and is especially effective against Gram-negative bacteria, including the hard-to-treat Pseudomonas aeruginosa.
Tobramycin is available in several forms:
For a deeper dive into how this drug works, check out our article on Tobramycin's mechanism of action.
Tobramycin works by binding irreversibly to the 30S ribosomal subunit of bacterial ribosomes. This blocks the bacteria's ability to translate mRNA into functional proteins. Without the proteins they need to survive and reproduce, the bacteria die.
This mechanism is shared across the aminoglycoside class of antibiotics, which means other aminoglycosides can often serve as alternatives — though each has slightly different strengths, coverage, and side effect profiles.
The right alternative depends on what you're being treated for. Here's a breakdown by condition:
Drug class: Aminoglycoside antibiotic
Available forms: Ophthalmic drops, ophthalmic ointment, IV/IM injection, topical cream
How it compares: Gentamicin is the closest relative to Tobramycin. It covers a similar range of Gram-negative bacteria and works by the same mechanism. For eye infections, Gentamicin ophthalmic drops are a very common substitute — they're widely available, inexpensive (often under $10 with a discount card), and effective against the same types of bacteria.
For systemic infections, Gentamicin injection is widely used in hospitals as an alternative to Tobramycin. However, Tobramycin is generally preferred for Pseudomonas infections because it has slightly better activity against that organism.
Key consideration: Like Tobramycin, Gentamicin carries risks of nephrotoxicity (kidney damage) and ototoxicity (hearing damage), especially with IV use. Your doctor will monitor you closely.
Drug class: Aminoglycoside antibiotic
Available forms: IV/IM injection, inhalation (Arikayce for non-CF lung disease)
How it compares: Amikacin has the broadest spectrum of all aminoglycosides. It retains activity against many bacteria that have developed resistance to Tobramycin and Gentamicin. This makes it a valuable option for multidrug-resistant Gram-negative infections.
Amikacin is typically reserved for more serious or resistant infections and is used primarily in hospital settings. It's not available as an eye drop, so it's not a substitute for Tobramycin ophthalmic.
Key consideration: Amikacin has a higher risk of ototoxicity compared to other aminoglycosides, so hearing monitoring is important during treatment.
Drug class: Fluoroquinolone antibiotic
Available forms: Ophthalmic drops (Vigamox, Moxeza), oral tablets, IV injection
How it compares: For bacterial eye infections, Moxifloxacin eye drops are one of the most commonly prescribed alternatives to Tobramycin. Moxifloxacin has broader coverage than Tobramycin, including better activity against Gram-positive bacteria like Staphylococcus and Streptococcus, while still covering many Gram-negatives.
Research has shown that fluoroquinolone eye drops are just as effective as aminoglycoside drops for most bacterial conjunctivitis cases. Generic Moxifloxacin eye drops typically cost $15 to $30 without insurance.
Key consideration: Moxifloxacin doesn't require as frequent dosing as Tobramycin — usually 3 times daily versus every 4 hours — which can make it more convenient.
Drug class: Monobactam antibiotic
Available forms: Inhalation solution (with Altera nebulizer)
How it compares: For cystic fibrosis patients who rely on inhaled Tobramycin (TOBI) to manage chronic Pseudomonas lung infections, Cayston (aztreonam lysine) is a well-established alternative. Like TOBI, it's used in alternating 28-day on/off cycles and targets Pseudomonas aeruginosa specifically.
Some CF treatment plans alternate between TOBI and Cayston — using one during the on-cycle and the other during the next on-cycle — to reduce the risk of antibiotic resistance.
Key consideration: Cayston requires a specific nebulizer (the Altera system) and is expensive at $7,000 to $9,000+ per month without insurance. Prior authorization is typically required. Novartis and Gilead both offer patient assistance programs.
Here's a summary to help you and your doctor decide:
If you can't find Tobramycin, bring these questions to your next appointment:
For help finding a prescriber who can evaluate your options, see our guide on finding a doctor who prescribes Tobramycin.
Not being able to fill your Tobramycin prescription is stressful, but you have options. Whether your doctor switches you to Gentamicin for an eye infection, Amikacin for a resistant systemic infection, or Cayston for a CF lung infection, there are proven alternatives available.
Start by checking Medfinder to see if Tobramycin is available near you before switching — the shortage may not affect every pharmacy. And for more tips on locating your medication, visit our guide on how to find Tobramycin in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.